Worse results seen after PCI in diabetes patients with STEMI

12/27/2011 | Medscape (free registration)

Diabetes patients who had percutaneous stenting for ST-segment elevation myocardial infarction appeared to face a greater risk of heart attack, target lesion revascularization and all-cause mortality than those who did not have diabetes, a study in the American Journal of Cardiology found.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA